Stock Details
2269.T is Meiji Holdings Co., Ltd.'s stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 6,258.00¥. Average daily volumn in 3 months 509.4k. Market cap 879.55B

Stock symbol : 2269.T. Exchange : Tokyo. Currency : JPY
Lastest price : 3,155.00¥. Total volume : 1.26M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Meiji Holdings Co., Ltd. (2269.T)
Last Price

Previous Close3,150.00
Day Range3,150.00-3,185.00
Bid3,150.00 x N/A
Ask3,165.00 x N/A
Average Volume509.4k
Market Cap879.55B
52 Week Range3,145.00-7,130.00
Trailing P/E11.35
Foward P/E15.73
Dividend (Yield %)2.69%
Ex-Dividend Date2023-03-30

Financial Details

According to Meiji Holdings Co., Ltd.'s financial reports the company's revenue in 2022 were 1.01T an decrease(0%) over the years 2021 revenue that were of 1.19T. In 2022 the company's total earnings were 87.5B while total earnings in 2021 were 65.66B( +33.85%).

Loading ...


Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs,... corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Market Cap:
Total Assets:
Total Cash:

News about "Meiji Holdings Co., Ltd."

Meiji Holdings Co. Ltd. ADR

Source from : Wall Street Journal - 12 days ago

1 Day MEJHY -0.38% DJIA 1.20% S&P 500 0.89% Consumer Goods 0.28% Kazuo Kawamura President & Representative Director Global Dairy Platform, Meiji Holdings Co., Ltd., Meiji Co., Ltd., Japan Dairy ...See details»

Meiji Holdings

Source from : Forbes - 9 days ago

Meiji Holdings Co., Ltd. engages in the management of its subsidiaries with business activities focusing on food and pharmaceutical production. It operates through the Food and Pharmaceutical ...See details»

Meiji Holdings Co., Ltd. (2269.T)

Source from : Yahoo Finance - 20 hours ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»

Meiji Holdings Co Stock (OTC:MEJHF), Dividends

Source from : - 6 month ago

Meiji Holdings Co issues dividends to shareholders from excess cash Meiji Holdings Co generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly ...See details»


Infant Formula Ingredients Global Market Report 2023: Focus on Infant Care and Nutrition is Expected to Drive the Market

Source from : YAHOO!Finance - 2 days ago

This report provides strategists, marketers and senior management with the critical information they need to assess the market.The global infant formula ingredients market grew from $19.77 billion in ...See details»

Yogurt Market 2023 Size and Forecast to 2030

Source from : MarketWatch - 5 days ago

Yogurt Marketinformation for each competitor includes (Nestle, Arla Foods, Yakult, Chobani LLC, Bright Food (Group) ...See details»

Meiji Yasuda Life Insurance Company

Source from : BN Americas - 2 years ago

Subscribe to the most trusted business intelligence platform in Latin America. Let us show you our solutions for Suppliers, Contractors, Operators, Government, Legal, Financial and Insurance.See details»


Why Arcturus Therapeutics Shares Are Moving Higher After Hours

Source from : Business Insider - 3 days ago

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are booming in Tuesday's after-hours session after the company reported fourth-quarter results and provided an update on ...See details»

Beauty Supplements Market Size From 2023 To 2029 And Unlimited Opportunities for New Companies

Source from : MarketWatch - 3 days ago

To know How COVID-19 and Russia-Ukraine War Influence Will Impact This Market/Industry - Request a sample copy of the report-: Moreover, the Beauty Supplements Market Report includes data on research ...See details»


Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On?

Source from : Business Insider - 3 days ago

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are trading higher Wednesday after the company reported strong fourth-quarter results and provided an update on pipeline progress.See details»

Why Arcturus Therapeutics Stock Is Soaring Today

Source from : The Motley Fool on MSN - 3 days ago

Arcturus handily topped analysts' estimates on both the top and bottom lines. And the company provided an update on its pipeline progress. It said that its partner, Meiji Pharma, completed full ...See details»

Truly International Holdings

Source from : Forbes - 3 days ago

Truly International Holdings Ltd. operates as an investment holding company. The company through its subsidiaries engages in the manufacturing and selling of liquid crystal display products and ...See details»

The Tata Power Company Ltd.

Source from : - 1 days ago

*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.See details»

The Global Doxorubicin Market is forecast to grow by $469.97 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period

Source from : Yahoo Finance - 10 days ago

The analyst has been monitoring the doxorubicin market and is forecast to grow by $469.97 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period.New York, March 22, 2023 ...See details»